• Publications
  • Influence
Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage
Cartilage destruction in osteoarthritis (OA) is thought to be mediated by two main enzyme families; the matrix metalloproteinases (MMPs) are responsible for cartilage collagen breakdown, whereasExpand
A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
PURPOSE Dupuytren's disease (DD) is a common fibrotic condition of the palmar fascia, leading to deposition of collagen-rich cords and finger contractions. The metzincin superfamily contains keyExpand
Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis.
OBJECTIVE Increasing evidence implicates serine proteinases in pathologic tissue turnover. The aim of this study was to assess the role of the transmembrane serine proteinase matriptase in cartilageExpand
Differential Toll-like receptor-dependent collagenase expression in chondrocytes.
OBJECTIVES To characterise the catabolic response of osteoarthritic chondrocytes to Toll-like receptor (TLR) ligands. METHODS Induction of the collagenases, matrix metalloproteinase (MMP)1 andExpand
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. WeExpand
Differential Toll-like receptor-dependent collagenase expression in chondrocytes
Degradome expression profiling in human articular cartilage
IntroductionThe molecular mechanisms underlying cartilage destruction in osteoarthritis are poorly understood. Proteolysis is a key feature in the turnover and degradation of cartilage extracellularExpand
Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation.
OBJECTIVE To examine the ability of a broad-spectrum histone deacetylase (HDAC) inhibitor to protect cartilage in vivo, and to explore the effects of class-selective HDAC inhibitors and smallExpand
Sulforaphane Represses Matrix-Degrading Proteases and Protects Cartilage From Destruction In Vitro and In Vivo
Objective Sulforaphane (SFN) has been reported to regulate signaling pathways relevant to chronic diseases. The aim of this study was to investigate the impact of SFN treatment on signaling pathwaysExpand
...
1
2
3
4
5
...